Startup entity
Every one of those 1 sits in a single category, leadership. Of the tracked stories, 1 of 1 also mention Bambusa Therapeutics, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.6 for that window.
Last mentioned: Mar 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, leadership. Of the tracked stories, 1 of 1 also mention Bambusa Therapeutics, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.6 for that window. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. We currently track 1 Startup story that mention Todd James, all published on March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 48 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Todd James. Shared-story counts are live from our verified record — not editorial picks.
CFO Appointment
Bambusa Therapeutics officially announces Todd James as the new Chief Financial Officer.
Industry Tenure
Todd James builds 20+ years of experience in biopharmaceutical leadership and finance.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical industry veteran with over 20 years of experience, as its new Chief Financial Officer. The strategic hire signals a focus on strengthening capital markets expertise and investor relations as the company advances its therapeutic pipeline.
Todd James is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
